Hone has 6 close competitors: Abridge, Alloy Therapeutics, Arthrex, Baylor Genetics.
Sector, valuation and status for each competitor.
A private valuation and a public market cap share one column; each row names its basis and date.
Hone
Abridge
Arthrex
Benchling
BioLinqLive learning platform for management training that combines expert-led small group training, peer learning, and continuous reinforcement for developing better leaders and managers.
Hone competes with 6 companies here: Abridge, Alloy Therapeutics, Arthrex, Benchling, BioLinq, Baylor Genetics.
No. Hone is a private company; its shares do not trade on a public exchange.
Lead investors for each round are in the funding timeline.
The closest healthcare peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
